A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Bristol-Myers Squibb
Bristol-Myers Squibb
Eli Lilly and Company
American Society of Clinical Oncology
Dana-Farber Cancer Institute
AstraZeneca
UNC Lineberger Comprehensive Cancer Center
University of California, San Diego
Pfizer
Lebanese University
Lebanese University
Peter MacCallum Cancer Centre, Australia
Shanghai Changzheng Hospital
Pfizer
Istituti Clinici Scientifici Maugeri SpA
Georgetown University
University of California, San Diego
GlaxoSmithKline